LumiThera, Inc., an ophthalmological medical device company, is in the process of commercializing non-invasive light-based therapeutic and diagnostic devices. These devices empower eye care specialists to diagnose, treat, and monitor degenerative eye diseases. The company’s primary focus thus far has centered on addressing dry age-related macular degeneration (AMD) in patients, utilizing its proprietary Valeda Light Delivery System. Notably, dry AMD stands as the leading cause of blindness among adults aged 60 and above.
